Health Care

4200 posts
Image of the human circulatory system

4DMedical secures $1.9M grant to ramp-up trials for ‘safer, cheaper’ lung imaging

The Federal government has awarded 4DMedical Ltd a grant worth $1.9M to fund its clinical trials…
Australian currency

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX…
Closeup of IV fluid

Tryptamine psilocin treatment ruled safe in IV infusion during early trial

Tryptamine Therapeutics Ltd has been told by a Safety Committee that its IV-infused psilocin therapy is…
Image of hands holding money

Telix Pharmaceuticals’ quarterly revenue exceeds AU$200M

Telix Pharmaceuticals (ASX:TLX) reveals its quarterly revenues while also reaffirming its full-year 2024 revenue guidance.
Medical project manager using a laptop

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

Healthcare informatics company Pro Medicus Ltd (ASX:PME) has signed a 5-year contract extension – valued at a minimum of $32 million –
Nasal spray bottle generic

LTR Pharma’s SPONTAN ‘nasal viagra’ absorbed 470% times faster than oral solution

LTR Pharma (ASX:LTP) has posted final study results showing its 'nasal viagra' drug SPONTAN is absorbed…
The Market Online Video

Recce progresses testing of gel to treat bacterial skin infections

Recce Pharmaceuticals Ltd has reached an important milestone in testing of its R327G gel to treat…
Burn wound care

Orthocell wins first international approval for nerve repair product

West Australia-based regenerative medicine play Orthocell (ASX: OCC) has received regulatory approval from the Health Sciences…
Blood cancer illustrative concept

Leukaemia patient shows complete response in Chimeric Therapeutics’ latest trial

Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest…
CGI render of a human brain

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Neuren has confirmed it's received "positive" FDA responses for its Phase III trial to treat children…